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Predictors of Length of Stay Following 
Shoulder Arthroplasty in a High-Volume 
UK Centre 




Shoulder arthroplasty rates are increasing in the UK. No data has been published from a UK 
centre on predictors of length of inpatient stay following shoulder arthroplasty. This study 
aims to analyse the length of inpatient stay following shoulder arthroplasty in a high volume 
UK centre and identify predictors of prolonged inpatient stay. 
Materials and Methods: 
All shoulder arthroplasty cases performed between 2012-2018 were identified. A review of 
case notes and electronic patient record was completed to identify demographic data, 
Charlson co-morbidity score, length of inpatient stay and factors associated with length of 
stay. Multiple linear regression analysis was conducted to determine which factors were 
independently associated with length of inpatient stay.  
Results: 
640 shoulder arthroplasty cases were performed in 566 patients. Median length of stay was 2 
days. Length of stay was predicted by age, gender, chronic kidney disease, congestive cardiac 
failure, previous myocardial infarction, intraoperative complication and postoperative 
transfusion. 
Discussion: 
Increasing age, female sex, chronic kidney disease, congestive cardiac failure, previous 
myocardial infarction, intra-operative complication and transfusion were independent 
predictors of increased length of stay. Strategies to reduce perioperative complication and 
transfusion, and to optimise renal and cardiac comorbidities may reduce overall length of stay 
for shoulder arthroplasty patients. 




Rates of primary shoulder arthroplasty have consistently risen year on year over the last 
decade. In the UK, the National Joint Registry for England, Wales, Northern Ireland and the 
Isle of Man (NJR) began recording shoulder arthroplasty cases in 2012.(1) 6,526 cases were 
performed in 2017, this represents a 5.6 fold increase in annual rates of shoulder arthroplasty 
over the past 20 years.(1,2) 
 
Whilst it is positive that an increasing number of patients have access to the beneficial 
shoulder specific and overall lifestyle effects of arthroplasty for end-stage glenohumeral 
arthropathies, (3-5) the rise in demand confers a significant increase in burden on healthcare 
resources. In the UK, the National Health Service (NHS) has recently experienced a period of 
unprecedented rising demand with below inflation funding leading to a provider sector deficit 
of £960million in 2017/18.(6) This has led to increased scrutiny on resource allocation, with 
elective orthopaedic procedures commonly targeted for healthcare cost savings. In addition to 
this funding shortfall, seasonal peaks in demand have consistently led to bed shortages and 
cancellation of elective surgery over the winter months.(7) It is therefore vital for any unit 
offering shoulder arthroplasty to understand the implications of providing shoulder 
arthroplasty on the utilisation of inpatient beds. 
 
In the United States of America (USA), several papers have evaluated the length of stay 
following shoulder arthroplasty and identified predictors of increased length of stay. Dunn et 
al. analysed 2,004 patients undergoing primary elective total shoulder arthroplasty reporting a 
mean length of stay of 2.2 days and identifying age, female sex, renal insufficiency and ASA 
grade of 3 or above as predictive of increased length of stay.(8) In a further study, Menendez 
et al. analysed 40,869 patients who underwent elective total shoulder arthroplasty, they also 
identified age, female sex and renal failure as associated with increased length of stay. In 
addition, they reported that COPD, pre-operative anaemia, and low volume centres were 
associated with prolonged inpatient stay.(9) 
 
To date there has been no study of patient and surgical factors associated with increased 
length of inpatient stay following shoulder arthroplasty in the UK. This study aims to address 
this evidence gap by reporting the length of inpatient stay following shoulder arthroplasty in a 
high volume UK centre and identify factors associated with greater length of stay.
Materials and Methods: 
A consecutive series of shoulder arthroplasties performed at the host institution, a tertiary 
referral upper limb unit, between January 2012 and January 2018 was identified. Patients 
were included if they underwent any form of shoulder arthroplasty, including anatomic total 
shoulder replacement, reverse total shoulder replacement, hemiarthroplasty and revision 
procedures for all indications. Patients were excluded if they did not receive a shoulder 
arthroplasty procedure, no cases were excluded for incomplete data. A review of case notes, 
electronic patient record, operation notes, anaesthetic charts and discharge summaries was 
conducted to collect patient demographic data, co-morbidities, details of inpatient stay and 
date of death. Length of  stay was defined as the number of nights spent in an acute inpatient 
bed. The Charlson co-morbidity index, a validated scoring system used to predict mortality 
based on a patient’s co-morbidities was calculated for each patient.(10)  
 
This study was performed under the jurisdiction of the HRA and their decision 







Descriptive statistical analysis was carried out using Microsoft Excel (Microsoft Corporation, 
Redmond, Washington, USA.). Multiple linear regression analysis was performed using 
GraphPad InStat and Prism (GraphPad Software Inc, La Jolla, CA, USA). Significance was 
determined when p < 0.05. 
 
In the multiple linear regression model, independent variables included were age, gender, 
ASA grade (1-2, 3-4), Charlson co-morbidity index, comorbidities (diabetes, liver failure, 
malignancy, chronic kidney disease, congestive cardiac failure, myocardial infarction, 
chronic obstructive pulmonary disease, peripheral vascular disease, cerebrovascular accident, 
connective tissue disorder and peptic ulcer), trauma or elective surgery, primary or revision 
surgery, indication for primary surgery (osteoarthritis, cuff tear arthropathy, other), year of 
surgery (2011-2014, 2015-2017), type of shoulder arthroplasty (hemiarthroplasty, anatomical 
total shoulder replacement, reverse geometry shoulder replacement), side of operation, hand 
dominance, anaesthetic (general anaesthetic or general anaesthetic plus regional block), 
operating surgeon grade (Consultant or training grade), previous surgery (arthroscopic 
surgery, arthroplasty surgery, open reduction internal fixation), fixation of humeral 
component (cemented or uncemented), intraoperative complication and postoperative 
transfusion. Comorbidities of AIDS, dementia and hemiplegia were excluded as there were 
no cases. Multicollinearity was assessed and addressed where it was a problem (R2>0.75); it 
was addressed either by grouping variables as described above (e.g. ASA grade and year of 
surgery) or removal of variables from the model (e.g. day of the week of surgery) until it was 
no longer a problem (R2<0.75 for all variables). 
 
Results: 
During the study period 640 shoulder arthroplasty cases were performed in 566 patients. The 
mean age at time of surgery was 72 years (SD±10), 451 cases (70%) were performed in 
female patients. The most common procedure was primary reverse total shoulder replacement 
(287 cases; 45%) followed by primary anatomic total shoulder replacement (262 cases; 41%) 
and hemiarthroplasty (36 cases; 6%), 55 revision procedures were undertaken. Of the cases 
performed 569 (89%) were elective cases, with 71 (11%) due to trauma. The most common 
indication was osteoarthritis (289 cases, 45%), followed by rotator cuff arthropathy (160 
cases; 25%). Demographic details broken down by length of stay for all patients included are 
provided in Table 1 for illustration of trends. 
 
  
Table 1. Patient Demographic Data 
 
The median length of stay and a breakdown of median length of stay by patient and surgical 
factors is shown in Table 2, the mean and standard deviation is also included to allow 
comparison to published data. The median length of inpatient stay was 2 days (IQR 2-4) and 
the mean was 4 days (SD+-6), 348 patients stayed for 1 or 2 days, 210 patients stayed 
between 3-7 days and 82 patients had an inpatient stay of greater than 7 days (see Fig. 1). 
 
Univariate comparisons suggested that patients who required inpatient stays of greater than 
the median were older (mean age 74yrs vs. 70 yrs), more likely to be female (80% vs. 63%), 
had a higher Charlson Co-Morbidity Index (4 vs. 3) and were more likely to have undergone 
surgery for trauma (19% vs. 8%). Analysis of length of stay by patient and surgical factors 
demonstrated patients over 79yrs had double the length of stay of younger patients (4 days vs. 
2 days), female patients had a median length of stay of 3 days vs. 2 days for males and that a 
Charlson Co-Morbidity Index of 6-9 was associated with a 4 times longer inpatient stay when 
compared to patients with a score of 0-3. 
Table 2. Length of Inpatient Stay by Indicative Patient and Surgical Factors. 
 
Figure 1. Number of patients who stayed for each time period. 
 
The analysis of variance indicated that the multiple regression model did significantly predict 
length of stay. The length of stay was predicted by the following variables in the model (table 
1): age, gender, chronic kidney disease, congestive cardiac failure, previous myocardial 
infarction, intraoperative complication and postoperative transfusion. None of the other 
variables independently predicted length of stay.  
 
Table 3. Multiple regression model investigating factors that significantly predict increasing 
length of inpatient stay following shoulder arthroplasty. 
Discussion: 
 
This is the first study to determine factors associated with length of inpatient stay following 
shoulder arthroplasty in a UK population. We found a median inpatient stay of 2 days (IQR 
2-4). 348 (54%) patients achieved discharge in 2 days or less with 83 (13%) patients 
requiring an inpatient stay of greater than 7 days. The length of stay was predicted by age 
(p=0.033), gender (p=0.021), chronic kidney disease (p=0.0008), congestive cardiac failure 
(p=0.035), previous myocardial infarction (p=0.030), intraoperative complication (p=0.014) 
and postoperative transfusion (p=0.0006) on multivariate analysis. 
 
The 2 day median length of stay reported here is less than the 3 day (IQR 2-5) median length 
of stay reported by Craig et al. in their study of 51,585 shoulder replacement carried out in 
the UK between 1998-2017.(2) The 4 day mean length of stay is longer than the figure 
reported by Dunn et al. who reported a 2.2 day mean length of inpatient stay in 2,004 primary 
elective total shoulder arthroplasties, with 91% of patients achieving discharge from hospital 
in 3 days or less, compared to 67% in this study.(8) Padegimas et al. reported a length of stay 
of 1.3 days in an orthopaedic specialist hospital, and 1.9 days in a tertiary referral centre 
when examining 2 groups of 136 patients, matched by baseline characteristics, who 
underwent primary total shoulder arthroplasty.(11) These figures may not be entirely 
comparable though as these cases were all primary procedures, performed electively, and it is 
common practice in the USA for elective orthopaedic patients to be discharged to a 
rehabilitation facility prior to home. Length of stay is also influenced in our institution by day 
case procedures being prioritised for early positioning on the operating list, with arthroplasty 
often undertaken later in the day. 
 
In a study of 40,869 patients who underwent elective primary total shoulder arthroplasty, 
Menendez et al. identified increasing age, female sex, renal failure, congestive heart failure, 
COPD and anaemia as factors associated with prolonged length of inpatient stay.(9) Dunn et 
al. also identified increasing age, female sex, chronic renal disease and higher co-morbidity 
scores as predictive of prolonged length of stay in his cohort of 2,004 patients.(8) The 
associations identified in this study between prolonged inpatient stay and increasing age, 
female sex, chronic renal failure and congestive cardiac failure are consistent with these 
previous findings. Previous myocardial infarction, intra-operative complication and post-
operative transfusion independently predicting prolonged length of stay has not been reported 
previously. 
 
Kim et al. examined the use of the Charlson Comorbidity Index and the Elixhauser 
Comornidity Measure in 90,491 patients who underwent primary elective total shoulder 
arthroplasty between 2002-2014 in Cleveland, Ohio. (12) They reported both measures to be 
good predictors of postoperative complication, prolonged inpatient stay, discharge to a 
rehabilitation facility and death.(12) Whilst the Charlson Comorbity Index was higher in 
patients with prolonged inpatient stay in this study, the Charlson score was not significantly 
associated with prolonged inpatient stay on multivariate analysis, so our findings do not 
support this Kim et al’s finding. However the Charlson co-morbidity index is made up of 
individual scores for co-morbidities, some of which were found to be independent predictors 
of prolonged length of stay, so our data suggest the effect on length of stay appears to arise 
from the individual co-morbidities rather than the overall Charlson Index. 
 
The limitations of this paper are that this was a retrospective study based on case note and 
medical record review and the numbers may have been too small to detect all significant 
associations on multivariate analysis.It must be stated that the numbers are small when 
compared to large national population level studies from the USA. These cases were 
performed in a high-volume UK centre so may not be generalisable to all UK centres 
performing shoulder arthroplasty. The study here is designed to demonstrate an association 




This study reports the first data on length of stay following shoulder arthroplasty in a UK 
centre and the factors associated with prolonged inpatient stay. The findings are consistent 
with previously published work that increasing age, female sex, chronic renal failure and 
congestive cardiac failure are all associated with prolonged inpatient stay following total 
shoulder arthroplasty. Previous myocardial infarction, intra-operative complication and post-
operative transfusion were also identified and predictors of prolonged inpatient stay. This 
study provides useful single centre data in a UK population, and could be used in planning 
resource allocation for centres undertaking shoulder arthroplasty. This study also highlights 
the need for a larger in depth population level study of length of inpatient stay, and the factors 
associated with prolonged inpatient stay, in patients undergoing shoulder arthroplasty in the 
UK. 
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Length of Stay (Days)
Number of patients who stayed for each 
time period
Table 1. Patient Demographic Data by Length of Stay 
 
  All Patients Length of Stay 
    <3 days 3-7 days >7 days 
Number 640 348 210 82 
Age      
Mean (SD) 72 (+-10) 70 (+-10) 73 (+-9) 77 (+-9) 
Min 24 24 31 42 
Max 95 89 95 93 
Gender      
Male 189 129 45 15 
Female 451 219 165 67 
ASA      
1 52 40 12 0 
2 314 197 95 22 
3 265 109 101 55 
4 9 2 2 5 
Charlson Index      
Median (IQR) 3 (2-4) 3 (2-4) 4 (3-5) 4 (4-5) 
Procedure      
Anatomic 262 178 72 12 
Reverse 287 125 108 54 
Hemi 36 20 10 6 
Revision 55 25 20 10 
Indication      
OA 297 193 86 18 
RA 36 23 9 4 
Cuff arthropathy 160 69 64 27 
AVN 18 11 5 2 
Trauma 22 7 8 7 
Trauma sequelae 49 20 17 12 
Revision 55 25 20 10 
Infection 3 0 1 2 
Elective vs Trauma      
Elective 569 321 185 63 
Trauma 71 27 25 19 
Side      
Right 351 173 132 46 
Left 289 175 78 36 
Previous Surgery         
Yes 95 48 35 12 
No 545 300 175 70 
Table 2. Length of Inpatient Stay by Patient and Surgical Factors 
All Patients Length of Stay (Days) 
Median (IQR) 2 (2-4) 






























































Table 3: Multiple regression model investigating factors that significantly predict increasing length of 






t value p value 
Age 0.137 0.011 to 0.263 2.141 0.0327 
Gender 1.091 0.165 to 2.018 2.314 0.0210 
ASA 1-2 or 3-4 -0.861 -1.820 to 0.098 1.763 0.0784 
Charlson Score -0.340 -1.549 to 0.870 0.5519 0.5812 
Diabetes 0.566 -1.226 to 2.358 0.6207 0.5350 
Liver failure -3.815 -14.220 to 6.589 0.7201 0.4717 
Malignancy 1.299 -0.306 to 2.905 1.589 0.1125 
CKD 3.727 1.565 to 5.889 3.386 0.0008 
CCF 2.581 0.186 to 4.977 2.116 0.0348 
MI 2.672 0.265 to 5.078 2.180 0.0296 
COPD 0.843 -1.097 to 2.782 0.8533 0.3938 
PVD 2.621 -2.131 to 7.372 1.083 0.2792 
CVA -0.560 -3.140 to 2.020 0.4265 0.6699 
Connective tissue 0.836 -1.051 to 2.722 0.8700 0.3846 
Peptic ulcer 0.738 -2.155 to 3.632 0.5012 0.6164 
Trauma or elective 1.341 -0.566 to 3.247 1.381 0.1678 
Primary or revision -0.281 -0.642 to 0.084 <0.001 >0.9999 
Indication: OA -0.872 -2.531 to 0.787 1.032 0.3025 
Indication: cuff tear 
arthropathy -0.098 -1.841 to 1.646 0.110 0.9123 
Year 2011-4 or 2015-
7 -0.473 -1.365 to 0.419 1.042 0.2980 
Hemiarthroplasty -0.069 -0.711 to 0.573 <0.001 >0.9999 
Anatomical TSR -2.399 -8.721 to 4.021 <0.001 >0.9999 
Reverse TSR -2.871 -9.121 to 3.379 <0.001 >0.9999 
Side -0.150 -0.984 to 0.684 0.352 0.7247 
Hand dominance 1.585 -0.220 to 3.390 1.724 0.0852 
Anaesthetic (GA vs. 
GA+block) -0.551 -1.859 to 0.756 0.828 0.4081 
Operating surgeon 
grade 0.088 -0.867 to 1.042 0.180 0.8572 
Previous 
arthroscopy 0.315 -1.366 to 1.997 0.368 0.7129 
Previous ORIF -1.619 -5.139 to 1.901 0.903 0.3667 
Previous 
arthroplasty -2.739 -5.626 to 0.148 1.863 0.0630 
Humeral fixation -0.364 -1.604 to 0.878 0.575 0.5654 
Intraoperative 
complication 1.903 0.393 to 3.412 2.476 0.0136 
Postoperative 
transfusion 3.888 1.671 to 6.106 3.444 0.0006 
 
